Considering that CTLA-4 is a critical negative regulator of T-cell function and is involved in the mechanism of action of CD4+ CD25+ regulatory cells, the CTLA-4 gene, located on chromosome 2q33 region, seems to be a very attractive candidate gene with respect to MS susceptibility [112]. This evidence concerns the gene CTLA4 and myeloid sarcoma.